| 13:00-14:20 |
Poster Presentation 1 |
Moderator: Mi Hee Lim (Korea) |
| 13:00-13:02 |
Ethical Decision-Making Process for ECMO Bridging to Nowhere Patients: A Single-center Retrospective Study |
Takako Akimoto (Japan) |
| 13:02-13:04 |
Zero Recirculation (REC) and Cardiac Output (CO) in VV ECMO Patients |
Nikolai Krivitski (USA) |
| 13:04-13:06 |
Safety issue on Dual-Lumen Extracorporeal Membrane Oxygenation (ECMO) Cannulation Technique Using Transthoracic Echocardiography (TTE) during COVID-19 Outbreak |
Lin Huang (China) |
| 13:06-13:08 |
The novel weaning strategy converted from VAV to VV ECMO by applying pump-controlled retrograde trial off |
Kazuki Matsumura (Japan) |
| 13:08-13:10 |
Overt disseminated intravascular coagulation and antithrombin III predict bleeding and in-hospital mortality in patients undergoing extracorporeal membrane oxygenation |
Tae Wan Kim (Korea) |
| 13:10-13:12 |
The usability of ECMO Support in Tracheobronchial Airway Stenting |
Bong Soo Son (Korea) |
| 13:12-13:14 |
Examination of Complications in Decannulation of V-A ECMO |
Ryuhei Yoneda (Japan) |
| 13:14-13:16 |
Long-term survival outcome and the quality of life of patients with postcardiotomy venoarterial extracorporeal membrane oxygenator |
Poramin THEANPRAMUK (Thailand) |
| 13:16-13:18 |
Right Atrium and Pulmonary artery cannulation in extracorporeal life support. A nationwide perspective: Trends and Results |
Benjamin Friedrichson (Germany) |
| 13:18-13:20 |
The Safety of Near-infrared Spectroscopy-Directed Selective Distal Perfusion in Patients on Venoarterial Extracorporeal Membrane Oxygenation |
Seohee Joo (Korea) |
| 13:20-13:22 |
Pulse Pressure as a Potential Predictive Factor for Successful Weaning in Patients Supported by Venoarterial Extracorporeal Membrane Oxygenation without Left Ventricular Venting |
Jiseok Lee (Korea) |
| 13:22-13:24 |
Neurological prognosis and clinical analysis under ECMO after cardiac arrest |
Wu Tao (China) |
| 13:24-13:26 |
Extracorporeal membrane oxygenation treatment for traumatic subaxial cervical spine injury with SLIC score |
Dowan Kim (Korea) |
| 13:26-13:28 |
Flow patterns through side holes of venous cannula in mock circulation loop |
Dong Hoon Kang (Korea) |
| 13:28-13:30 |
Efficacy of V-V ECMO in obese patients with COVID-19-related ARDS：a retrospective study at three ECMO centers in Japan |
Yuichi Sato (Japan) |
| 13:30-13:32 |
Long-term survival and predictors of mortality in patients with veno-arterial-venous ECMO support |
Joohyung Son (Korea) |
| 13:32-13:34 |
Impact of morbid obesity on ECMO supported Covid-19 patient outcomes |
Agne Jankuviene (Lithuania) |
| 13:34-13:36 |
The “weekend effect” in extracorporeal cardiopulmonary resuscitation |
Kinam Shinv (Korea) |
| 13:36-13:38 |
Prolonged Veno-venous ECMO (Extracorporeal Membrane Oxygenation) in COVID-19 related ARDS |
Suji Oh (Korea) |
| 13:38-13:40 |
Ten-year outcomes of extracorporeal cardiopulmonary resuscitation in emergency department: A single-center experience |
Ji Seong Kim (Korea) |
| 13:40-13:42 |
Comparing left ventricular assist device and central extracorporeal membrane oxygenation as bridge to heart transplantation |
ilkun Park (Korea) |
| 14:40-16:00 |
Poster Presentation 2 |
Moderator: Lim Yongwhan (Korea) |
| 14:40-14:42 |
Argatroban Use in Extracorporeal membrane oxygenation (ECMO): Bleeding Complications and Risk Factors |
Seungwook Lee (Korea) |
| 14:42-14:44 |
Clustering analysis of viscoelastic hemostatic assays and conventional blood tests in V-V ECMO patients |
Yudai Iwasaki (Japan) |
| 14:44-14:46 |
Extracorporeal membrane oxygenation in acute poisoning: a systematic review and meta-analysis |
Hui Xin See Tow (Singapore) |
| 14:46-14:48 |
Association between hyperoxemia, survival, and neurological outcomes in ECPR patients undergoing TTM: A retrospective observational analysis of the SAVE-J Ⅱ study |
Tomoaki Takeda (Japan) |
| 14:48-14:50 |
Percutaneous OxyRVAD in a Patient with Severe Respiratory Failure and Right Heart Failure |
Ga Young Yoo (Korea) |
| 14:50-14:52 |
New Noninvasive Method To Monitor Cardiac Recovery During VA ECMO* |
Nikolai Krivitski (USA) |
| 14:52-14:54 |
Outcomes of Extracorporeal Membrane Oxygenation in Coronavirus 19: A Single-Center Study |
Hojun Nam (Korea) |
| 14:54-14:56 |
Does Targeted Temperature Management improve outcome in ECPR patients or not? |
Ji Hwan Park (Korea) |
| 14:56-14:58 |
Sex difference in clinical outcomes following extracorporeal cardiopulmonary resuscitation |
Seung hyong Lee (Korea) |
| 14:58-15:00 |
Real-world clinical outcome in patients with shock treated by veno-arterial extracorporeal membranous oxygenator in Korea |
Eun-mi Kang (Korea) |
| 15:00-15:02 |
Initiation of venoarterial extracorporeal life support prior to cardiac arrest: Risk factors for in-hospital mortality |
Jun Ho Lee (Korea) |
| 15:02-15:04 |
Veno-Pulmonary artery canulation (V-Pa) for refractory hypoxemia in pregnant women with VV-ECMO support for SARS-CoV-2 infection |
Leonardo Salazar (Columbia) |
| 15:04-15:06 |
5-Year Single Center Experience: Peripheral Cannulation in VA-ECMO for Heart Transplantation |
Kyo Seon Lee (Korea) |
| 15:06-15:08 |
Comparative Evaluation of Surgical Decannulation Strategies in Patients Undergoing Femoral ECMO Insertion |
Siwon Oh (Korea) |
| 15:08-15:10 |
Pediatric Extracorporeal Membrane Oxygenation in Korea: A Multicenter Retrospective Study on Utilization and Outcomes Spanning over a Decade |
Younga Kim (Korea) |
| 15:10-15:12 |
Etiology and Outcomes of Cardiogenic Shock after Venoarterial Extracorporeal Membrane Oxygenation |
Jaeyoung Choi (Korea) |
| 15:12-15:14 |
Ultrasonographic Evaluation of Arterial Complications after Peripheral Venoarterial Extracorporeal Membrane Oxygenation Decannulation |
Yonghoon Shin (Korea) |
| 15:14-15:16 |
Novel tube surface modification with antithrombotic property: Towards improve ECMO treatment |
Hyung Jun Choi (Korea) |
| 15:16-15:18 |
The effect of mesenchymal stem cells and media on ECMO-induced systemic inflammatory response |
Hwa Jin Cho (Korea) |
| 15:18-15:20 |
High Incidence of Acute Kidney Injury in Extracorporeal Resuscitation, Leading to Poor Prognosis |
Dong Gi Kim (Korea) |
| 15:20-15:22 |
Unloading strategy in venoarterial extracorporeal membrane oxygenation with cardiogenic shock: Post hoc analysis of the EARLY UNLOAD Trial |
Yongwhan Lim (Korea) |
| 15:22-15:24 |
CHARACTERISTICS AND OUTCOMES OF CRITICALLY ILL COVID-19 PATIENTS RECEIVING EXTRACORPOREAL LIFE SUPPORT IN MILITARY HOSPITAL 175 COVID-19 TREATMENT CENTER |
Nguyen Canh Chung (Vietnam) |
| 16:20-17:40 |
Oral Presentation (Non-competition) |
Palle Palmer (Sweden),Sang Bum Hong (Korea) |
| 16:20-16:30 |
Improving Safety During ECMO Transport by Implementing Mobile tele-ICU |
Jun Hamaguchi (Japan) |
| 16:30-16:40 |
The role of Pediatric ECMO in limited resource center: A retrospective review |
Natakorn Harnhathya (Thailand) |
| 16:40-16:50 |
Do race and gender “matter” on Extracorporeal Membrane Oxygenation (ECMO)? |
Weiting Chen (USA) |
| 16:50-17:00 |
Hemodynamic effect of left ventricular unloading by trans-aortic catheter venting in peripheral veno-arterial extra-corporeal membrane oxygenation for cardiogenic shock: human-sized porcine model of acute hypoxic biventricular dysfunction |
Sang Yoon Kim (Korea) |
| 17:00-17:10 |
Predicting Complications through the Analysis of Blood Flow and Emboli Transport Patterns in Venoarterial Extracorporeal Membrane Oxygenation |
Mehrdad Khamooshi (Australia) |
| 17:10-17:20 |
Clinical Profile and Treatment Outcomes of Patients with Leptospirosis and Acute Respiratory Failure Who Underwent Extracorporeal Membrane Oxygenation at the National Kidney and Transplant Institute – Philippines |
Joann Kathleen Garcia (Philippines) |
| 17:20-17:30 |
Impact of Extracorporeal Life Support for a Refractory Out-of-Hospital Cardiac Arrest: Result from National Sudden Cardiac Arrest Survey |
Wan Kee Kim (Korea) |
